Delivery Order SPE2DB22D3102-SPE2DB25FL1PK
Award Date 5/30/25
Potential Completion Date 6/23/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $100,573.20 to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 unit vials, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. XEOMIN is a botulinum toxin product used in medical applications, and this order supports the federal...
- The Defense Logistics Agency awarded a $5,587.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of XEOMIN 200 Unit Vials, with performance to be completed by August 1, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. XEOMIN is a botulinum toxin product used in medical and therapeutic applications, and this delivery order...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of XEOMIN 100 UT vials valued at $9,498.58 under a firm fixed price contract type. The delivery order, which is expected to be completed by August 28, 2025, represents a non-competitive award with performance occurring at the awardee's facility in Conshohocken, Pennsylvania. XEOMIN is a botulinum toxin product commonly used in medical and cosmetic...
- The Defense Logistics Agency awarded a $1,955.59 delivery order to AmerisourceBergen Drug Corp for XEOMIN 100 Unit Vials, with an ultimate completion date of July 16, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. XEOMIN is a botulinum toxin product used in medical and cosmetic applications, procured through the federal supply chain for military and healthcare system use. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.70 to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN, a botulinum toxin product used for medical and therapeutic purposes. This competitive delivery order, issued on March 5, 2025, with an ultimate completion date of March 26, 2025, represents a firm fixed price procurement with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a $27,937 delivery order to AmerisourceBergen Drug Corp for XEOMIN 200 Unit Vials, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order, issued on July 31, 2025, represents a competitive, non-set-aside award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. XEOMIN is a botulinum toxin product used for medical and aesthetic purposes, reflecting the breadth of pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $16,762.20 to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 Unit Vials, a botulinum toxin product commonly used in medical and cosmetic applications. This firm fixed-price delivery order, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive award to the incumbent vendor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of XEOMIN 100 unit vials. This competitive delivery order, valued at $46,375.42, represents a firm fixed-price contract with an ultimate completion date of September 15, 2025. The award was not set-aside and reflects AmerisourceBergen's capability to meet federal pharmaceutical procurement requirements through open competition. The work will be...
- The Defense Logistics Agency awarded a $7,598.50 delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of XEOMIN 50 unit vials, with completion targeted for July 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed under open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $15,997.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of XEOMIN, a botulinum toxin product used for medical and cosmetic applications. The award, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen's Conshohocken, Pennsylvania facility serves as the place of performance for this transaction. This delivery...